Acute Myeloid Leukemia AML Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Acute Myeloid Leukemia (AML) Market is segmented By Therapy (Chemotherapy, Targeted Therapy, Immunot...

Acute Myeloid Leukemia AML Market Size

Market Size in USD Bn

CAGR7.7%

Study Period2025-2032
Base Year of Estimation2024
CAGR7.7%
Market ConcentrationMedium
Major PlayersBristol-Myers Squibb, AbbVie, Pfizer, F. Hoffmann-La Roche, Novartis and Among Others
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
setting-icon
Want to purchase customized report?
please let us know !

Acute Myeloid Leukemia AML Market Analysis

The Acute Myeloid Leukemia (AML) market is estimated to be valued at USD 1.74 billion in 2025 and is expected to reach USD 2.92 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2032.

The growing geriatric population who are susceptible to develop AML combined with the rising demand for targeted drug therapy for better treatment outcomes are key factors expected to drive the growth of the AML market.

Acute Myeloid Leukemia AML Market Report Snapshots

Acute Myeloid Leukemia AML Market Size